Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Mark F. Berry, MD"'
Autor:
Lye-Yeng Wong, MD, Ntemena Kapula, MS, Irmina A. Elliott, MD, Douglas Z. Liou, MD, Leah M. Backhus, MD, Natalie S. Lui, MD, Joseph B. Shrager, MD, Mark F. Berry, MD
Publikováno v:
Annals of Thoracic Surgery Short Reports, Vol 2, Iss 3, Pp 458-463 (2024)
Background: The technical complexity of segmentectomy and preservation of lung parenchyma compared with lobectomy vary by lobe. This study evaluated the impact of non-small cell lung cancer tumor location on segmentectomy use and outcomes. Methods: O
Externí odkaz:
https://doaj.org/article/6616ec1ec64642f3b701b551fea6cf65
Autor:
Yoyo Wang, BS, Ryan J. Randle, MD, Prasha Bhandari, MPH, Hao He, PhD, Winston L. Trope, BA, Brandon A. Guenthart, MD, H. Henry Guo, MD, Douglas Z. Liou, MD, Leah M. Backhus, MD, Mark F. Berry, MD, Joseph B. Shrager, MD, Natalie S. Lui, MD
Publikováno v:
JTCVS Open, Vol 20, Iss , Pp 202-209 (2024)
Objective: Robotic thoracic surgery provides another minimally invasive approach in addition to video-assisted thoracoscopic surgery (VATS) that yields less pain and faster recovery compared with open surgery. However, robotic incisions are generally
Externí odkaz:
https://doaj.org/article/588a73e170094074aff6344f19a47446
Autor:
Lye-Yeng Wong, MD, Yanli Li, PhD, Irmina A. Elliott, MD, Leah M. Backhus, MD, Mark F. Berry, MD, Joseph B. Shrager, MD, Daniel S. Oh, MD
Publikováno v:
JTCVS Open, Vol 18, Iss , Pp 234-252 (2024)
Objective: Randomized control trials are considered the highest level of evidence, yet the scalability and practicality of implementing randomized control trials in the thoracic surgical oncology space are not well described. The aim of this study is
Externí odkaz:
https://doaj.org/article/bafbae3c82674aee9a82359b69866970
Autor:
Yoyo Wang, BS, Ntemena Kapula, MS, Chi-Fu J. Yang, MD, Pooja Manapat, Irmina A. Elliott, MD, Brandon A. Guenthart, MD, Natalie S. Lui, MD, Leah M. Backhus, MD, Mark F. Berry, MD, Joseph B. Shrager, MD, Douglas Z. Liou, MD
Publikováno v:
JTCVS Open, Vol 16, Iss , Pp 855-872 (2023)
Objective: Failure to rescue (FTR), defined as in-hospital death following a major complication, has been increasingly studied in patients who undergo cardiothoracic surgery. This study tested the hypothesis that elderly patients undergoing lung canc
Externí odkaz:
https://doaj.org/article/d9d4f0b4ea6845878448d4b7874f3963
Autor:
Lye-Yeng Wong, MD, Irmina A. Elliott, MD, Douglas Z. Liou, MD, Leah M. Backhus, MD, Natalie S. Lui, MD, Joseph B. Shrager, MD, Mark F. Berry, MD
Publikováno v:
JTCVS Open, Vol 16, Iss , Pp 987-995 (2023)
Objective: Patients with esophageal cancer may be reluctant to proceed with surgery due to high complication rates. This study aims to compare outcomes between eligible surgical candidates who proceeded with surgery versus those who refused surgery.
Externí odkaz:
https://doaj.org/article/034132e28c214f9182f03b4dd26aebb8
Autor:
Lye-Yeng Wong, MD, Ntemena Kapula, MS, Hao He, PhD, Brandon A. Guenthart, MD, Lucas K. Vitzthum, MD, Kathleen Horst, MD, Douglas Z. Liou, MD, Leah M. Backhus, MD, Natalie S. Lui, MD, Mark F. Berry, MD, Joseph B. Shrager, MD, Irmina A. Elliott, MD
Publikováno v:
JTCVS Open, Vol 16, Iss , Pp 919-928 (2023)
Background: Radiotherapy (RT) is integral to breast cancer treatment, especially in the current era that emphasizes breast conservation. The aim of our study was to determine the incidence of subsequent primary lung cancer after RT exposure for breas
Externí odkaz:
https://doaj.org/article/a55d128d4c874072a2b7dcc82cb79977
Autor:
Lye-Yeng Wong, MD, Douglas Z. Liou, MD, Mohana Roy, MD, Irmina A. Elliott, MD, Leah M. Backhus, MD, Natalie S. Lui, MD, Joseph B. Shrager, MD, Mark F. Berry, MD
Publikováno v:
JTO Clinical and Research Reports, Vol 5, Iss 3, Pp 100654- (2024)
Introduction: Multiple clinical trials have revealed the benefit of immunotherapy (IO) for NSCLC, including unresectable stage III disease. Our aim was to investigate the impact of IO use on treatment and outcomes of potentially resectable stage IIIA
Externí odkaz:
https://doaj.org/article/0239d43c4ab64e1297be901985eb83c8
Autor:
Lye-Yeng Wong, MD, Douglas Z. Liou, MD, Leah M. Backhus, MD, Natalie S. Lui, MD, Joseph B. Shrager, MD, Mark F. Berry, MD
Publikováno v:
JTCVS Open, Vol 14, Iss , Pp 547-560 (2023)
Objective: Immunotherapy for esophageal cancer is relatively novel but increasingly used. This study evaluated the early use of immunotherapy as an adjunct to neoadjuvant chemoradiotherapy before esophagectomy for locally advanced disease. Methods: P
Externí odkaz:
https://doaj.org/article/297352eff92d48f9bd29c6d927d6f847